Literature DB >> 12957820

Citrate and mineral metabolism: kidney stones and bone disease.

Renata Caudarella1, Fabio Vescini, Angela Buffa, Segio Stefoni.   

Abstract

Citrate is a weak acid that is formed in the tricarboxylic acid cycle or that may be introduced with diet. In the present paper all the mechanisms involved in intestinal absorption, renal handling and modulation of citrate will be reviewed. The evaluation of plasma citric acid is scarcely used in the diagnosis of human diseases. On the contrary urinary citrate excretion is a common tool in the differential diagnosis of kidney stones, renal tubular acidosis and it plays also a role in bone diseases. Therefore the importance of hypocitraturia will be reviewed with regard to bone mass, urine crystallization and urolithiasis. Finally particular attention will be paid to the incidence of hypocitraturia and to the therapy with citrate salts, both in kidney stone disease and in osteopenia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12957820     DOI: 10.2741/1119

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  26 in total

1.  Net Acid Excretion and Urinary Organic Anions in Idiopathic Uric Acid Nephrolithiasis.

Authors:  I Alexandru Bobulescu; Sun K Park; L H Richie Xu; Francisco Blanco; John Poindexter; Beverley Adams-Huet; Taylor L Davidson; Khashayar Sakhaee; Naim M Maalouf; Orson W Moe
Journal:  Clin J Am Soc Nephrol       Date:  2019-02-11       Impact factor: 8.237

2.  Hypocitraturia: a risk factor for reduced bone mineral density in idiopathic hypercalciuria?

Authors:  Maria-Goretti Moreira Guimarães Penido; Eleonora Moreira Lima; Marcelo Ferraz Oliveira Souto; Viviane Santuari Parizotto Marino; Ana-Luiza Fialho Tupinambá; Anderson França
Journal:  Pediatr Nephrol       Date:  2005-10-27       Impact factor: 3.714

Review 3.  Calcium citrate: from biochemistry and physiology to clinical applications.

Authors:  Andrea Palermo; Anda Mihaela Naciu; Gaia Tabacco; Silvia Manfrini; Pierpaolo Trimboli; Fabio Vescini; Alberto Falchetti
Journal:  Rev Endocr Metab Disord       Date:  2019-09       Impact factor: 6.514

4.  Long-term potassium citrate therapy and bone mineral density in idiopathic calcium stone formers.

Authors:  F Vescini; A Buffa; G La Manna; A Ciavatti; E Rizzoli; A Bottura; S Stefoni; R Caudarella
Journal:  J Endocrinol Invest       Date:  2005-03       Impact factor: 4.256

5.  Plasma Citrate Homeostasis: How It Is Regulated; And Its Physiological and Clinical Implications. An Important, But Neglected, Relationship in Medicine.

Authors:  Leslie C Costello; Renty B Franklin
Journal:  HSOA J Hum Endocrinol       Date:  2016-12-31

6.  Idiopathic hypercalciuria and calcium renal stone disease: our cases.

Authors:  Federica Cioppi; Luca Taddei; Maria Luisa Brandi; Emanuele Croppi
Journal:  Clin Cases Miner Bone Metab       Date:  2009-09

7.  The general practitioner and nephrolithiasis.

Authors:  Emanuele Croppi; Federica Cioppi; Corrado Vitale
Journal:  Clin Cases Miner Bone Metab       Date:  2008-05

8.  Pediatric primary urolithiasis: Symptoms, medical management and prevention strategies.

Authors:  Maria Goretti Moreira Guimarães Penido; Marcelo de Sousa Tavares
Journal:  World J Nephrol       Date:  2015-09-06

9.  Citric acid effects on brain and liver oxidative stress in lipopolysaccharide-treated mice.

Authors:  Omar M E Abdel-Salam; Eman R Youness; Nadia A Mohammed; Safaa M Youssef Morsy; Enayat A Omara; Amany A Sleem
Journal:  J Med Food       Date:  2014-01-16       Impact factor: 2.786

Review 10.  Idiopathic hypercalciuria and formation of calcium renal stones.

Authors:  Fredric L Coe; Elaine M Worcester; Andrew P Evan
Journal:  Nat Rev Nephrol       Date:  2016-07-25       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.